Literature DB >> 12036393

Use of sensitivity functions to characterise and compare the forgiveness of drugs.

Patrice Nony1, Jean-Pierre Boissel.   

Abstract

In order to compare the capacity for forgiveness of different drugs, i.e. the sensitivity of their effects to sporadic noncompliance, we propose the use of 'sensitivity functions' for drugs acting through direct pharmacokinetic-pharmacodynamic relationships. This approach is based on the concept of the partial derivative dE/dC (with E corresponding to the pharmacodynamic effect and C to the concentration of drug at the effect site), and the study of the variation of this function in terms of its maximum and inflexion points. Values of sensitivity functions are given for the three common direct response models, i.e. the linear, maximum effect (hyperbolic) and Hill (sigmoid) models. The capacity for forgiveness of drugs differing only by one parameter in their pharmacokinetic-pharmacodynamic relationship is assessed using this approach and illustrated with theoretical simulated examples. Examples of clinical application are then proposed, dealing with the effect of nifedipine on heart rate and diastolic blood pressure, and loop diuretics on natriuretic response, in patients with and without liver cirrhosis. Although the study of sensitivity functions is proposed as a theoretical approach, the relationships between noncompliance and its consequences for pharmacodynamic effect remain highly complex and, in most cases, numerical simulation is still needed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036393     DOI: 10.2165/00003088-200241050-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  10 in total

Review 1.  Clinical pharmacology of loop diuretics in health and disease.

Authors:  D C Brater
Journal:  Eur Heart J       Date:  1992-12       Impact factor: 29.983

Review 2.  Revisiting the effect compartment through timing errors in drug administration.

Authors:  P Nony; M Cucherat; J P Boissel
Journal:  Trends Pharmacol Sci       Date:  1998-02       Impact factor: 14.819

Review 3.  A pharmacokinetic perspective on medicament noncompliance.

Authors:  G Levy
Journal:  Clin Pharmacol Ther       Date:  1993-09       Impact factor: 6.875

Review 4.  Kinetics of pharmacologic response.

Authors:  N H Holford; L B Sheiner
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

Review 5.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

6.  The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension.

Authors:  G Parati; S Omboni; D Rizzoni; E Agabiti-Rosei; G Mancia
Journal:  J Hypertens       Date:  1998-11       Impact factor: 4.844

Review 7.  Role of patient compliance in clinical pharmacokinetics. A review of recent research.

Authors:  J Urquhart
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

8.  Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration.

Authors:  C H Kleinbloesem; J van Harten; J P Wilson; M Danhof; P van Brummelen; D D Breimer
Journal:  Clin Pharmacol Ther       Date:  1986-07       Impact factor: 6.875

9.  The impact of patient compliance on drug concentration profile in multiple doses.

Authors:  W Wang; F Husan; S C Chow
Journal:  Stat Med       Date:  1996-03-30       Impact factor: 2.373

10.  Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact.

Authors:  J Urquhart
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

  10 in total
  6 in total

1.  A pharmacokinetic and pharmacodynamic analysis of drug forgiveness.

Authors:  Noel P McAllister; Sean D Lawley
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-02-13       Impact factor: 2.745

2.  Should patients skip late doses of medication? A pharmacokinetic perspective.

Authors:  Elias D Clark; Sean D Lawley
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-06-20       Impact factor: 2.410

Review 3.  Regeneration and bioengineering of the kidney: current status and future challenges.

Authors:  Marcus Salvatori; Andrea Peloso; Ravi Katari; Giuseppe Orlando
Journal:  Curr Urol Rep       Date:  2014-01       Impact factor: 3.092

4.  Compliance assessment of ambulatory Alzheimer patients to aid therapeutic decisions by healthcare professionals.

Authors:  Oliver Schwalbe; Christian Scheerans; Ines Freiberg; Andrea Schmidt-Pokrzywniak; Andreas Stang; Charlotte Kloft
Journal:  BMC Health Serv Res       Date:  2010-08-09       Impact factor: 2.655

5.  A methodological framework for drug development in rare diseases.

Authors:  Patrice Nony; Polina Kurbatova; Agathe Bajard; Salma Malik; Charlotte Castellan; Sylvie Chabaud; Vitaly Volpert; Nathalie Eymard; Behrouz Kassai; Catherine Cornu
Journal:  Orphanet J Rare Dis       Date:  2014-11-18       Impact factor: 4.123

6.  Quantification of the Forgiveness of Drugs to Imperfect Adherence.

Authors:  P Assawasuwannakit; R Braund; S B Duffull
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.